Tuesday, April 04, 2017 5:39:17 PM
Stock Split
On November 22, 2016, the Company filed a Certificate of Change with the Secretary of State of the State of Nevada to effect a reverse stock split of its outstanding and authorized shares of common stock at a ratio of 1 for 30 (the “Reverse Stock Split”). Upon the effectiveness of the Reverse Stock Split, the Company’s issued and outstanding shares of common stock was decreased from approximately 28,323,588 to 944,120 shares, all with a par value of $0.001. The Company has no outstanding shares of preferred stock.
Accordingly, all share and per share information has been restated to retroactively show the effect of the last three Reverse Stock Splits.
In addition, the Company increased authorized shares of common stock from 40,000,000 to 500,000,000 shares and its authorized shares of preferred stock remained at 4,000,000 shares.
Recent TLSS News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:00:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 02:00:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 02:00:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/08/2023 09:01:37 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 09:16:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 01:00:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/21/2023 01:00:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/14/2023 01:00:42 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/06/2023 04:15:06 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 08/24/2023 03:37:38 PM
- Shares Pop Following Logistics and Transportation Expansion into New England • AllPennyStocks.com • 08/22/2023 03:30:00 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 08/16/2023 03:24:01 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 09:00:24 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 08/03/2023 08:05:11 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 08/02/2023 08:15:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/19/2023 01:00:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/12/2023 01:00:09 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM